At a glance
Reye syndrome is a rare serious illness causing acute dysfunction of the brain and liver.
Repeated vomiting, lethargy, behavioral change, or confusion can appear suddenly as a child seems to recover.
Disease Atlas / Disease detail
An evidence-bounded guide to acute brain and liver dysfunction after viral illness, aspirin-associated risk, emergency evaluation, and supportive care.
Reye syndrome · Reye's syndrome
Start with the essentials, then explore the patient and research views.
Public revision · 045150cde970
A structured guide for understanding the disease and preparing for clinical conversations.
Reye syndrome is a rare serious illness causing acute dysfunction of the brain and liver.
Repeated vomiting, lethargy, behavioral change, or confusion can appear suddenly as a child seems to recover.
It occurs mainly in children and adolescents after a viral illness such as influenza or chickenpox.
Aspirin use during viral illness is associated with increased risk and should not be given to children without specialist direction.
Progression can cause seizures, reduced consciousness, and coma, requiring emergency assessment.
Diagnosis integrates the clinical course, blood and liver tests, ammonia, and exclusion of other causes.
Imaging, cerebrospinal-fluid testing, or liver biopsy may be used when needed to assess alternative disorders.
There is no specific medicine that reverses Reye syndrome; intensive supportive care is central.
Pain and fever medicines for children should be selected after checking ingredients and consulting a clinician.
Clinical discussion should cover recent infection, medicines, symptom progression, metabolic and toxic differentials, and intensive-care needs.
This material is for disease education and is not a personal diagnosis or treatment instruction.
A trial registry status does not establish efficacy or regulatory approval.
MedlinePlus · GOVERNMENT SUMMARY
MedlinePlus Medical Encyclopedia · CLINICAL SUMMARY
National Institute of Neurological Disorders and Stroke · GOVERNMENT SUMMARY
U.S. Food and Drug Administration · REGULATORY GUIDANCE